Sort
8,912 grants matching “sars cov 2”
ACTIV TRACE support at NCBI for SARS-CoV-2
$2,354,179Kathryn Freeland · A-Tek, Inc. · N02 · FY2023 · LM
Maternal Omics to Maximize Immunity
$2,353,983Douglas A Lauffenburger · Massachusetts Institute Of Technology · U19 · FY2024 · AI
Maternal Omics to Maximize Immunity
$2,353,983Douglas A Lauffenburger · Massachusetts Institute Of Technology · U19 · FY2022 · AI
Maternal Omics to Maximize Immunity
$2,353,983Douglas A Lauffenburger · Massachusetts Institute Of Technology · U19 · FY2023 · AI
Maternal Omics to Maximize Immunity
$2,353,983Douglas A Lauffenburger · Massachusetts Institute Of Technology · U19 · FY2025 · AI
Adeno-associated Virus Biology And Utilization For Gene Transfer
$2,352,017Jay Chiorini · National Institute Of Dental & Craniofacial Research · ZIA · FY2021 · DE
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2
$2,350,878Jane C. Figueiredo · Cedars-Sinai Medical Center · U54 · FY2023 · CA
Structural and chemical biology of membrane proteins
$2,347,622Anirban Banerjee · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
Human anti-viral immune responses in tissues and circulation
$2,343,548Donna L Farber · Columbia University Health Sciences · U19 · FY2025 · AI
Human anti-viral immune responses in tissues and circulation
$2,343,548Donna L Farber · Columbia University Health Sciences · U19 · FY2022 · AI
Human anti-viral immune responses in tissues and circulation
$2,343,548Donna L Farber · Columbia University Health Sciences · U19 · FY2024 · AI
Human anti-viral immune responses in tissues and circulation
$2,343,548Donna L Farber · Columbia University Health Sciences · U19 · FY2023 · AI
Collision of Alzheimers disease and COVID-19 pandemic in the United States: risks, outcomes, disparities and treatments
$2,342,002Rong Xu · Case Western Reserve University · RF1 · FY2022 · AG
Development and Proof-of-Concept Implementation of the South Florida Miami RADx-rad SARS-CoV-2 Wastewater-Based Surveillance Infrastructure
$2,341,239Helena Solo-Gabriele · University Of Miami Coral Gables · U01 · FY2022 · DA
Improvements to the Regional Biocontainment Research Facilities at the University of Missouri
$2,340,729Christian L. Lorson · University Of Missouri-Columbia · G20 · FY2022 · AI
Innate and Adaptive Immune Responses in SARS-CoV-2 infection (COVID-19)
$2,333,309Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross
$2,332,322Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2020 · AI
LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)
$2,331,636Susan H Eshleman · Johns Hopkins University · UM1 · FY2021 · AI
Genetics and Epigenetics of Cardiovascular Disease
$2,329,046Gary Gibbons · National Human Genome Research Institute · ZIA · FY2022 · HG
Durable Alteration of the Human Immune system after Infection or Immunotherapy
$2,328,551Raymond T Chung · Massachusetts General Hospital · U19 · FY2025 · AI
Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center
$2,314,795Richard G Wunderink · Northwestern University At Chicago · U19 · FY2025 · AI
COVID-19: External Quality Assurance Program Oversight Laboratory (EQAPOL)
$2,307,858Tom Denny · Duke University · N01 · FY2021 · AI
Optimizing SARS-CoV-2 wastewater based surveillance in urban and university campus settings.
$2,304,069Anne-Catrin Uhlemann · Columbia University Health Sciences · U01 · FY2022 · DA
Single-molecule measurements of DNA topology and topoisomerases
$2,302,231Keir Neuman · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
System Biological Analyses of Adaptive Responses to vaccination
$2,300,069Rafi Ahmed · Emory University · U19 · FY2020 · AI